Table 1.
Data on Adherence and Clinical Outcomes of Peer and Page Support Interventions by Arm at all Assessment Points
| All participants | Usual care participants | Pager Arm participants | Peer Arm participants | Pager and Peer Arm participants | |
|---|---|---|---|---|---|
| M(SD) N = 224 | M(SD) n = 57 | M(SD) n = 56 | M(SD) n = 57 | M(SD) n = 54 | |
| Dose Adherence | |||||
| Self-Report 100% (1-week) | |||||
| 2 weeks | 69.6 | 64.9 | 80.4 | 63.2 | 70.4 |
| 3 Months | 57.6 | 47.4 | 57.1 | 56.1 | 70.4 |
| 6 Months | 50.9 | 63.2 | 42.9 | 42.1 | 55.6 |
| 9 Months | 49.1 | 43.9 | 58.9 | 43.9 | 50.0 |
| EDM % (1-week) | |||||
| 2 weeks | 62.7 (41.2) | 63.0 (41.5) | 63.0 (41.9) | 61.7 (41.2) | 63.2 (41.1) |
| 3 Months | 44.4 (42.8) | 38.7 (43.0) | 41.8 (42.6) | 47.0 (44.6) | 50.1 (41.2) |
| 6 Months | 37.7 (42.8) | 41.0 (44.0) | 36.9 (42.6) | 37.2 (44.5) | 35.4 (40.9) |
| 9 Months | 32.5 (41.5) | 29.1 (39.7) | 36.5 (44.2) | 32.3 (42.5) | 32.1 (40.0) |
| HIV-1 RNA viral load (Log10 copies/ml) | |||||
| Baseline | 4.4 (1.3) | 4.3 (1.2) | 4.5 (1.2) | 4.6 (1.2) | 4.3 (1.4) |
| 3 Months | 3.1 (1.7) | 3.2 (1.7) | 3.1 (1.8) | 3.3 (1.8) | 2.8 (1.6) |
| 6 Months | 3.3 (1.9) | 3.0 (1.7) | 3.4 (1.9) | 3.8 (2.0) | 3.0 (1.7) |
| 9 Months | 3.4 (1.9) | 3.5 (1.9) | 3.2 (1.8) | 3.5 (2.0) | 3.1 (1.8) |
| Across 3 follow-upsa | 39.3% | 31.6% | 42.9% | 33.3% | 50.0% |
| CD4 count (cells/mm3) | |||||
| Baseline | 204.5 (166.8) | 198.5 (160.4) | 194.3 (149.8) | 229.2 (153.1) | 195.4 (202.3) |
| 3 Months | 246.3 (215.9) | 232.5 (204.2) | 256.2 (223.2) | 246.6 (209.4) | 250.3 (231.7) |
| 6 Months | 248.4 (218.2) | 255.6 (222.8) | 235.3 (214.2) | 259.6 (238.8) | 242.4 (199.1) |
| 9 Months | 259.0 (234.9) | 243.5 (216.7) | 254.6 (206.6) | 280.0 (258.2) | 257.7 (258.9) |
| Across 3 follow-upsb | 17.0% | 12.3% | 19.6% | 21.1% | 14.8% |
a
Percentage of participants with HIV-1 RNA viral load < 1000 copies/ml at all three follow-up assessments
b
Percentage with CD4 count > 350 cells/mm3 at all three follow-up assessment